Navigation Links
Mass. Launches Criminal Probe of Firm Linked to Meningitis Outbreak: Report
Date:10/25/2012

By Steven Reinberg and Margaret Steele
HealthDay Reporters

WEDNESDAY, Oct. 24 (HealthDay News) -- Massachusetts officials said Tuesday that they have launched a criminal investigation into the specialty pharmacy at the center of the fungal meningitis outbreak that has now sickened 317 people in 17 states and killed 24.

State inspectors said they found unsanitary conditions that included black specks of fungus in steroids made at the New England Compounding Center, CBS News reported.

And state regulators have voted to permanently revoke the pharmacy's license, the Worcester Business Journal reported Wednesday.

The inspectors' preliminary investigation also revealed that the company distributed drugs before the return of tests to check for sterility. They added that the company functioned as a drug manufacturer, producing drugs for broad use, rather than filling individual prescriptions for individual doctors, in violation of its state license, CBS News reported.

The network also said the inspectors found dirty floor mats, a leaky boiler, inadequate sterilization of medications and improper testing of laboratory equipment.

The company said it was cooperating with investigators, CBS said.

According to published reports, state records showed that the New England Compounding Center was plagued by problems as far back as 2006.

Those records, obtained by the Associated Press under a public documents request, showed there was evidence of inadequate contamination control and no written standard operating procedures for using equipment, among other problems, at the facility.

Those problems were corrected that year, the AP reported.

The New England Compounding Center is what's known as a compounding pharmacy. These pharmacies combine, mix or alter ingredients to create specific drugs to meet the specific needs of individual patients, according
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Mass. Eye and Ear, Joslin Diabetes announce collaboration in eye care
2. Mass. Eye and Ear Researcher receives RPB Award
3. Mass. Eye and Ear and HMS department of ophthalmology receives RPB Grant
4. First web-based prostate cancer database launches
5. UT MD Anderson Cancer Center launches unprecedented Moon Shots Program
6. $20 million gift launches new hub for global health at UCSF
7. Tate & Lyle launches TASTEVA™ Stevia sweetener
8. A breath of fresh air: Childhood Asthma Leadership Coalition launches
9. Germany launches a €16 million epigenome program
10. NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths
11. Dallas Launches Insecticide Spraying Against West Nile Virus
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mass. Launches Criminal Probe of Firm Linked to Meningitis Outbreak: Report
(Date:9/1/2015)... ... September 01, 2015 , ... ... managed, stress created from everyday life changes can lead to very serious, life-altering ... support for coping with stress. Herbal supplement manufacturer MediHerb has coupled ...
(Date:9/1/2015)... ... September 01, 2015 , ... From Aug. 17-21, Calvary Hospital hosted the ... 6-18. Calvary’s Camp Compass® has taken place at Kingsborough Community College in Brooklyn in ... of whom work for Calvary, and two junior counselors who were campers themselves just ...
(Date:9/1/2015)... ... , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has once ... Style 50 Report that recognizes companies that provide the best career opportunities for Hispanic ... from number 24 to 21 of the 50 Best Companies for Latinas. The LATINA ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... better therapeutic options to efficiently cure and prevent different malignancies. Some options ... have different pathophysiological properties due to which distinctive approach is necessary for ...
(Date:9/1/2015)... ... September 01, 2015 , ... As part of its ... Shield of Minnesota (Blue Cross) has announced Doctor On Demand as the company’s ... Doctor On Demand provides immediate access to Board Certified physicians or next-day appointments ...
Breaking Medicine News(10 mins):Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3
... cardiac cells may make them more resilient during real attack, ... Doctors have long known that the creation of a ... blood flow to arteries -- can actually reduce the damage ... know how that protective effect occurs, according to research from ...
... groups concerned about growing rates of obesity, diabetes, heart ... other illness linked to chemical exposure, said today that ... administrator with expertise and information for solutions to the ... , With so many different chemicals ...
... Dec. 12 [The Washington Post Friday ... Drug Administration and the White House are considering easing the ... fish. Scientists at the Environmental Protection Agency reportedly are ... move is one of several "midnight" rules and policy changes ...
... have better prognosis, study finds , , FRIDAY, Dec. 12 (HealthDay ... increase the risk of getting breast cancer, but women who ... lower risk of dying from the disease, a new study ... a particular type of cancer that is easier to treat," ...
... THE U.S. COMMITMENT TO GLOBAL HEALTH: RECOMMENDATIONS FOR THE ... is an important investment for the United States, even ... report describes areas that require the most attention, emphasizes ... and makes specific recommendations regarding funding and coordination of ...
... disease stabilize or improve, study shows , , FRIDAY, ... of medicines designed to boost immune function can ... results from an ongoing Mayo Clinic study. , ... drug called pomalidomide with dexamethasone (pom/dex) improved or ...
Cached Medicine News:Health News:Research Explains Benefit of 'Mini Heart Attack' 2Health News:Scientists, Physicians, Health, and Environmental Justice Advocates to New Obama EPA Director: 'We Look Forward to Toxic Chemical Regulatory Reform' 2Health News:HRT Users Who Get Breast Cancer Less Likely to Die 2Health News:HRT Users Who Get Breast Cancer Less Likely to Die 3Health News:Combo Therapy Helps Multiple Myeloma Patients 2
(Date:9/1/2015)... , September 1, 2015 ... on the basis of sectors, products & services ... globally coupled with the increasing demand of advanced ... expected to propel the growth for bioinformatics market. ... information efficiently is known as bioinformatics. Decreasing cost ...
(Date:9/1/2015)... , Aug. 31, 2015 Research and ... the "Regulatory Affairs for Support Staff (London, UK ... This two day course provides an ... drug development and has been designed specifically for those ... You will gain an overview of EU regulatory procedures ...
(Date:9/1/2015)... LONDON , September 1, 2015 - ... of GARFIELD-AF R egistry data presented ... real-world insights on the evolution of ... -   The first-ever two-year ... showcased at ESC Congress 2015 expose that all-cause death was the most frequent ...
Breaking Medicine Technology:Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4Regulatory Affairs for Support Staff Seminar (London, UK - September 24-25, 2015) 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9
... the newest and most advanced automated immunoassay ... AIA-1800 launches with a full menu of ... reproductive, cardiac, and anemia assays. ,The AIA-1800 ... primary tube sampling, auto dilution, auto pretreatment, ...
EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis...
... name from its first known site of ... of PSA circulates bound to anti-chymotrypsin (PSA-ACT) ... PSA are elevated in patients with prostate ... [1-3]. In addition, PSA serum levels appear ...
... Functional Vision, Quality of Vision and ... both target illumination and glare luminance ... results. Day/Night testing with/without glare and ... and all ANSI standards. All Light ...
Medicine Products: